The effect of intravenous sodium valproate versus dexamethasone on acute migraine headache
Phase 3
- Conditions
- Acute migraine headache.Migraine with or without aura
- Registration Number
- IRCT201202199014N1
- Lead Sponsor
- Vic-Chancellor of Research and Technology, Hamadan University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 72
Inclusion Criteria
Age of 18 to 65 years; history of having migraine for at least one year; severity of headache equal to or greater than 5 VAS
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Severity of headache. Timepoint: At baseline and then 0.5 hour and 2 hours later. Method of measurement: Visual Analogue Scale (VAS).
- Secondary Outcome Measures
Name Time Method Any side effect such as allergy. Timepoint: 0.5 hour and 2 hours later. Method of measurement: Questionnaire.